These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9466649)

  • 1. 4-Aminobiphenyl-DNA adducts and p53 mutations in bladder cancer.
    Martone T; Airoldi L; Magagnotti C; Coda R; Randone D; Malaveille C; Avanzi G; Merletti F; Hautefeuille A; Vineis P
    Int J Cancer; 1998 Feb; 75(4):512-6. PubMed ID: 9466649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of 4-aminobiphenyl-DNA adducts in human breast cancer: the influence of tobacco smoke.
    Faraglia B; Chen SY; Gammon MD; Zhang Y; Teitelbaum SL; Neugut AI; Ahsan H; Garbowski GC; Hibshoosh H; Lin D; Kadlubar FF; Santella RM
    Carcinogenesis; 2003 Apr; 24(4):719-25. PubMed ID: 12727801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels.
    Landi MT; Zocchetti C; Bernucci I; Kadlubar FF; Tannenbaum S; Skipper P; Bartsch H; Malaveille C; Shields P; Caporaso NE; Vineis P
    Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):693-8. PubMed ID: 8877060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenyl-hemoglobin adduct levels.
    Probst-Hensch NM; Bell DA; Watson MA; Skipper PL; Tannenbaum SR; Chan KK; Ross RK; Yu MC
    Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):619-23. PubMed ID: 10868698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of 4-ABP-DNA adducts and p53 alterations in urinary bladder carcinoma.
    Romano G; Garagnani L; Boninsegna A; Ferrari P; Flamini G; De Gaetani C; Sgambato A; Giovanni F; Curigliano G; Ferretti G; Cittadini A; Trentini G
    Anticancer Res; 1999; 19(5C):4571-6. PubMed ID: 10650812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP1A2 and NAT2 phenotyping and 3-aminobiphenyl and 4-aminobiphenyl hemoglobin adduct levels in smokers and non-smokers.
    Sarkar M; Stabbert R; Kinser RD; Oey J; Rustemeier K; von Holt K; Schepers G; Walk RA; Roethig HJ
    Toxicol Appl Pharmacol; 2006 Jun; 213(3):198-206. PubMed ID: 16405939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Black (air-cured) and blond (flue-cured) tobacco cancer risk. IV: Molecular dosimetry studies implicate aromatic amines as bladder carcinogens.
    Bartsch H; Malaveille C; Friesen M; Kadlubar FF; Vineis P
    Eur J Cancer; 1993; 29A(8):1199-207. PubMed ID: 8518034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of 4-aminobiphenyl-DNA adducts in bladder cancer biopsies.
    Airoldi L; Orsi F; Magagnotti C; Coda R; Randone D; Casetta G; Peluso M; Hautefeuille A; Malaveille C; Vineis P
    Carcinogenesis; 2002 May; 23(5):861-6. PubMed ID: 12016161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical quantitation of 4-aminobiphenyl-DNA adducts and p53 nuclear overexpression in T1 bladder cancer of smokers and nonsmokers.
    Curigliano G; Zhang YJ; Wang LY; Flamini G; Alcini A; Ratto C; Giustacchini M; Alcini E; Cittadini A; Santella RM
    Carcinogenesis; 1996 May; 17(5):911-6. PubMed ID: 8640937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of TP53 in repair of N-(deoxyguanosin-8-yl)-4-aminobiphenyl adducts in human transitional cell carcinoma of the urinary bladder.
    Torino JL; Burger MS; Reznikoff CA; Swaminathan S
    Carcinogenesis; 2001 Jan; 22(1):147-54. PubMed ID: 11159753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alkylaniline-hemoglobin adducts and risk of non-smoking-related bladder cancer.
    Gan J; Skipper PL; Gago-Dominguez M; Arakawa K; Ross RK; Yu MC; Tannenbaum SR
    J Natl Cancer Inst; 2004 Oct; 96(19):1425-31. PubMed ID: 15467031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunochemical, 32P-postlabeling, and GC/MS detection of 4-aminobiphenyl-DNA adducts in human peripheral lung in relation to metabolic activation pathways involving pulmonary N-oxidation, conjugation, and peroxidation.
    Culp SJ; Roberts DW; Talaska G; Lang NP; Fu PP; Lay JO; Teitel CH; Snawder JE; Von Tungeln LS; Kadlubar FF
    Mutat Res; 1997 Aug; 378(1-2):97-112. PubMed ID: 9288889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer.
    Firozi PF; Bondy ML; Sahin AA; Chang P; Lukmanji F; Singletary ES; Hassan MM; Li D
    Carcinogenesis; 2002 Feb; 23(2):301-6. PubMed ID: 11872636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences between human slow N-acetyltransferase 2 alleles in levels of 4-aminobiphenyl-induced DNA adducts and mutations.
    Bendaly J; Doll MA; Millner LM; Metry KJ; Smith NB; Pierce WM; Hein DW
    Mutat Res; 2009 Dec; 671(1-2):13-9. PubMed ID: 19682468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA adducts in urothelial cells: relationship with biomarkers of exposure to arylamines and polycyclic aromatic hydrocarbons from tobacco smoke.
    Vineis P; Talaska G; Malaveille C; Bartsch H; Martone T; Sithisarankul P; Strickland P
    Int J Cancer; 1996 Jan; 65(3):314-6. PubMed ID: 8575850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carotenoids/vitamin C and smoking-related bladder cancer.
    Castelao JE; Yuan JM; Gago-Dominguez M; Skipper PL; Tannenbaum SR; Chan KK; Watson MA; Bell DA; Coetzee GA; Ross RK; Yu MC
    Int J Cancer; 2004 Jun; 110(3):417-23. PubMed ID: 15095308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetylation phenotype, carcinogen-hemoglobin adducts, and cigarette smoking.
    Vineis P; Caporaso N; Tannenbaum SR; Skipper PL; Glogowski J; Bartsch H; Coda M; Talaska G; Kadlubar F
    Cancer Res; 1990 May; 50(10):3002-4. PubMed ID: 2334904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutathione S-transferase M1 genotype affects aminobiphenyl-hemoglobin adduct levels in white, black and Asian smokers and nonsmokers.
    Yu MC; Ross RK; Chan KK; Henderson BE; Skipper PL; Tannenbaum SR; Coetzee GA
    Cancer Epidemiol Biomarkers Prev; 1995 Dec; 4(8):861-4. PubMed ID: 8634658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. White blood cell DNA adducts, smoking, and NAT2 and GSTM1 genotypes in bladder cancer: a case-control study.
    Peluso M; Airoldi L; Armelle M; Martone T; Coda R; Malaveille C; Giacomelli G; Terrone C; Casetta G; Vineis P
    Cancer Epidemiol Biomarkers Prev; 1998 Apr; 7(4):341-6. PubMed ID: 9568791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular epidemiology of bladder cancer.
    Vineis P; Martone T
    Ann Ist Super Sanita; 1996; 32(1):21-7. PubMed ID: 8967722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.